Links : [H]ard|Folding [H]ard|OCP
Local

Pacific

Mountain

Central

Eastern

GMT

[H] Member Login

Remember
NAVIGATION
[H]ard|Folding
Back to Main
Folding@Home
How To Join
Project Faqs
Project Add-ons
[H] Members
[H]orde Members
[H]ard|Farming
[H]ard|Wallpaper
Statistics
F@H Statistics
[H] UD statistics
Unofficial
WCG Statistics
Contributors
[H]|Folding Council
Contributors

Powered by the [H]ard|OCP ServerPowered by PHP
Folding@Home Information

Stanford's goal: to understand protein folding, protein aggregation, and related diseases.



What are proteins and why do they "fold"? Proteins are biology's workhorses -- its "nanomachines." Before proteins can carry out their biochemical function, they remarkably assemble themselves, or "fold." The process of protein folding, while critical and fundamental to virtually all of biology, remains a mystery. Moreover, perhaps not surprisingly, when proteins do not fold correctly (i.e. "misfold"), there can be serious effects, including many well known diseases, such as Alzheimer's, Mad Cow (BSE), CJD, ALS, and Parkinson's disease.

What does Folding@Home do? Folding@Home is a distributed computing project which studies protein folding, misfolding, aggregation, and related diseases. Stanford uses novel computational methods and large scale distributed computing, to simulate timescales thousands to millions of times longer than previously achieved. This has allowed us to simulate folding for the first time, and to now direct Stanford's approach to examine folding related disease.



How to Join | Project Faqs | Project Add-ons | Statistics | Download Client
New Members
[ 2 ]
 Alarzeth0805/23/13 
 dndavis5705/21/13 
Active Members
Cancer News
Anti-Cancer Drug Reverses Alzheimer's Disease In Mice
Promising Early Results For Use Of Poliovirus Vaccine In Recurrent Glioblastoma
Radioactive Nanoparticles Developed That Target Cancer Cells
New Tumour Killer Developed By Scientists
Frequent Heartburn Increases Risk Of Throat Cancer By 78%
Grapefruit-Derived Nanovectors Provide A Secret Weapon In Medical Drug Delivery
Minimizing Hair Loss Due To Cancer Radiation Therapy
Researchers Develop Model For Better Testing, Targeting Of MPNST
Compound In Mediterranean Diet Makes Cancer Cells 'Mortal'
Reducing Your Risk Of Breast Cancer
Small Cancer Risk Following CT Scans In Childhood And Adolescence Confirmed
Epigenetic Regulators And NF-Kappa B May One Day Be Targeted For The Treatment Of Cancer
Software May Allow Doctors To Track Progression Of Cancer, Response To Treatment, And Risk Of Relapse
Outcome In Head And Neck Cancer Predicted By Genetic Diversity Within Tumors
Cancer Survivors Suffer Physical & Emotional Impairments Which Often Go Untreated
UK Aims To Make Genetic Testing Available To All Cancer Patients
Depressive Symptoms Are Linked To Early Death In Cancer Survivors
Non-Surgical Treatments For Multiple Tumors Move One Step Closer
Study Finds Broad Support For Rationing Of Some Types Of Cancer Care
Advanced Prostate Cancer Drug Xofigo Approved By FDA
Study Suggests Cutaneous Squamous Cell Carcinoma Carries Risk Of Metastasis And Death
Data Addressing Patient And Physician Barriers To Clinical Trials To Be Presented By Experts
Bankruptcy An Increased Risk Following Cancer Diagnosis
Blocking The Protein-Protein Interaction Which Causes Ewing Sarcoma
Molecular Profiling Timely For Tailoring Cancer Therapy
Alzheimer's News
Anti-Cancer Drug Viewed As Possible Alzheimer's Treatment Doesn't Work In UF Study
Anti-Cancer Drug Reverses Alzheimer's Disease In Mice
Class Of Drugs Discovered That Could Lead To The Development Of A Silver Bullet For Combatting Alzheimer's Disease
Alzheimer's Cause Found In Trigger Of Brain Protein Malfunction
Identification Of Molecular Trigger For Alzheimer's Disease
Aging Brains May Benefit More From Mediterranean Than Low Fat Diet
Relationship Discovered Between Sleep Apnea And Alzheimer's Disease
Mediterranean Diet Seems To Boost Ageing Brain Power
News From Frontiers In Endocrinology, Microbiology, Physiology
Skin Cancer Link To Lower Risk Of Alzheimer's Disease, Says Study
Assessing The Efficacy Of Different Types Of Training Programs On Cognitive Performance In Elderly Patients
Detect Alzheimer's Disease Years Before Memory Loss And Cognitive Decline Become Apparent
Drug Improves Memory In Mice With Alzheimer's Disease
Obesity-Related Dementia Is Projected To Rise In England
Leukemia Drug Prevents Build-Up Of Toxic Brain Protein
Mutations In Genes That Regulate Cellular Metabolism Found In Families With Ataxia, Dementia And Reproductive Failure
A Patient's Right To Control Genomic Health Information
Association Between Alzheimer's Disease And Removal Of The Synaptic Protein ADAM10
Scientists Bring Clarity To How Most Alzheimer's Drugs Sharpen Brain Performance
Rethinking Therapeutic Strategies That Target APOE To Slow Amyloid Plaque Accumulation And Alzheimer's
Problems Processing Everyday Events Linked To Older Adults' Memory Lapses
Study Examines Cognitive Impairment In Families With Exceptional Longevity
How Environmental Stimuli And Brain Rhythms Generate Our Neuronal Maps Of The World
Study Finds Late-Life Depression Associated With Increased Risk For Dementia
Early Detection Of Alzheimer's Disease Expected In The Next Five To Ten Years
Biochemistry News
[H]ard|Folding News Articles
  • Stickies: 0
  • News Articles: 142
  • Pages: 29
Protein In The Brain Could Be A Key Target In Controlling Alzheimer's
King_N
[H]ard|Folding Administrator


Posts: 87
Points: 2,416,520
Work Units: 6,104

Posted: Sun Jan 29, 2012 06:43 pm
This has been a relatively quiet month, there has been no new news released by the Stanford folding team, so there is not much I can report.

However I did run across this interesting Alzheimer's news article.

Quote:
A protein recently discovered in the brain could play a key role in regulating the creation of amyloid beta, the major component of plaques implicated in the development of Alzheimer's disease, according to researchers at Temple University's School of Medicine.

A group led by Domenico Pratico, professor of pharmacology and microbiology and immunology at Temple, discovered the presence of the protein, called 12/15-Lipoxygenase, in the brain three years ago.

"We found this protein to be very active in the brains of people who have Alzheimer's disease," said Pratico. "But three years ago, we didn't know the role it played in the development of the disease."

Following two years of study, the Temple researchers have found that the protein is at the top of a pathway and controls a biochemical chain reaction that begins the development of Alzheimer's.


Full Article here
Multiple Myeloma First Risk Genes Discovered
King_N
[H]ard|Folding Administrator


Posts: 87
Points: 2,416,520
Work Units: 6,104

Posted: Thu Dec 29, 2011 07:55 pm
It's been a rather slow month for news.

Stanford has finished their stats re-credit, they ask that you let them know if there is still problems.


On the cancer news front

Quote:
According to a paper published online in Nature Genetics, a team of scientists led by The Institute of Cancer Research (ICR) has demonstrated for the first time that a person's genes influence their risk of developing multiple myeloma, a cancer of plasma cells, which is a type of white blood cell responsible for the production of antibodies.


Full Article here


Also there was a slight problem with the database earlier this month, the site was down for a short time while the issue was dealt with. Everything appears to be back to normal.

Recent video about Folding@home from the Stanford News Service
King_N
[H]ard|Folding Administrator


Posts: 87
Points: 2,416,520
Work Units: 6,104

Posted: Sat Nov 26, 2011 05:25 pm
Stanford has released a video about Folding.



View Video here


Also Stanford has made changes to the "Big Advanced Projects" which will go into effect Jan 16th.


Quote:

Big Advanced (BA) is an experimental type of Folding@home WUs intended for the most powerful machines in FAH. However, as time goes on, technology advances, and the characteristics associated with the most powerful machines changes. Due to these advances in hardware capabilities, we will need to periodically change the BA minimum requirements. Thus, we are shortening the deadlines of the BA projects. As a result, assignments will have a 16 core minimum. To give donors some advance warning, we are announcing this now, but the change will take place in 2 months: no earlier than on Monday January 16, 2012.

We understand that any changes to how FAH works is a disruption for donors, and we have been trying to minimize such changes. For that reason, we are not changing the points system at this time.

However, we want to emphasize that the BA program is experimental and that donors should expect changes in the future, potentially without a lot of notice (although we will try our best to give as much notice as we can). In particular, as hardware evolves, it is expected that we will need to change the nature of the BA WUs again in the future.
Folding Client 7.1.38 Released
King_N
[H]ard|Folding Administrator


Posts: 87
Points: 2,416,520
Work Units: 6,104

Posted: Tue Oct 25, 2011 03:05 pm
A New Folding Client has been released, v7.1.38

Changelog for the last few updates is below.

Quote:
v7.1.38:
Fixed network connection dropping.


v7.1.37:
Added missing wraplabel.py file to FAHControl.
Changed socket error message verbosity.
Fail WU on UNSTABLE_MACHINE immediately & return for partial credit. #615


v7.1.36:
Fixed a potential socket connection bug. Maybe related to #734.
Added several NVidia cards to GPUs.txt. #737.
Improved Linux on battery detection. #738.
Print WU error state on WU status line.
Emit correct exception on FAH transaction failure. #615.
Fixed debian package install core permissions problem. #732.
Removed core byte order warning. #602.
Added GPL link to FAHControl about. #736.
Ask user, team, passkey and mode during .deb package install. #739.


v7.1.35:
Added 'Enchanter' theme. #731
Renamed 'Wimp' to 'Windows-Default'. #731
Unminimize FAHControl window on unhide. #567
Better core download failure message. #161
Cleaned up project descriptions using html2text.py.
Store project data in client DB.
Use system default font size. #733
Added project info to viewer. #575.
Added clickable buttons to viewer.
Fixed FAHViewer crash introduced in v7.1.34.
Fixed mouse wheel scrolling in FAHControl. #463.
Fixed color difference for text boxes. #698.
Changed FAHControl window name. #711.


v7.1.34:
Fixed CPU consumption in client connections. #702
Really fixed "Wrong architecture" bug on 32-bit Ubuntu. #599
Only warn on config errors. #722
Log error and continue of command server fails to initialize.
Fixed Slot configuration text. #717
Use -1 or 0 for CPUs default to be consistent with GPU options. #717
Disabled no longer supported AMD X1300 - 1900 GPUs.
Added "OpenGL Render" to info in FAHViewer. (For blacklisting)
Added 'override-blacklist' option to FAHViewer. (Nothing black listed yet)
'OK' -> 'Save' in FAHViewer preferences window. #724
Fixed NVIDIA_DEV.1244.01 = "NVIDIA GeForce GTX 550 Ti" detection.
Added the 'Wimp' theme and win32 theme engines. #723
Made 'Wimp' theme the default in Windows. #713
Added heartbeat to viewer<->client connection to timeouts dead connections.
Stop trying FAILED, FAULTY and DUMP reports if WS connection was made. #728
Check WS server versions for unreasonable values. #728.


Client Download: here



Stanford also released a paper showing the Comparison between FAH and Anton's approaches.

Quote:
Right now, the two most powerful supercomputers for studying protein folding are Folding@home and a very impressive special purpose computer from DE Shaw Researched, called ANTON. We're often been asked "how do they compare?" The approaches are very different, so comparisons aren't completely straightforward. ANTON takes the traditional approach to studying protein folding, where one performs a few (often 1 or 2) long trajectories to study the process. Folding@home takes a statistical approach, which has two primary benefits: 1) it can access folding on dramatically longer timescales (milliseconds, instead of microsecond folding events over a single long trajectory) and 2) it can give statistically significant results on those long timescales.

The main concern about the method in FAH is that since it is such a radically new approach, does it work reliably? Previous tests of FAH have been to experiment, which is the gold standard test, but also brings in other issues, such as how good are our models of reality. Thus, while FAH's approach has done well compared to experiment, it is useful to compare FAH and ANTON directly, since they use the same models, etc. Comparison of our statistical approach (using Markov State Models, aka MSMs) directly with data from ANTON would go a long way to showing that the MSM approach works for even non-trivial systems (they have been previously tested for long dynamics on small systems).


Full Article: here


Award-winning research points toward Alzheimers vaccine
King_N
[H]ard|Folding Administrator


Posts: 87
Points: 2,416,520
Work Units: 6,104

Posted: Wed Sep 28, 2011 06:46 pm
There really hasn't been any new news from Stanford this month, however I did run across this article dealing with research that could possibly lead to an Alzheimer's vaccine.

Quote:
AUGUSTA, Ga. An accomplice to the protein that causes plaque buildup in Alzheimers disease is the focus of a potential new treatment, according to research by a Georgia Health Sciences University graduate student.

In Alzheimers, the amyloid protein can accumulate in the brain instead of being eliminated by the bodys natural defenses, nestling between the neurons and forming impassable plaques.

Amyloid and the way it gets there could be targets for a new vaccine.


Full article here.
  • Stickies: 0
  • News Articles: 142
  • Pages: 29
Who's Online
Administrator Council News Member
[H]ard|Folding Copyright © 2001 - 2013 by King_N,   [H]ard|OCP Copyright © 1998 - 2013 by Kyle Bennett

All trademarks used are properties of their respective owners. All rights reserved.